Home
Conditions
B Cell Lymphoma

Clinical trial condition

B Cell Lymphoma

Explore clinical trials studying B Cell Lymphoma. Study availability and eligibility vary by location and protocol.

41 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

B Cell Lymphoma trial results

Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CN1

NCT04418141

Conditions: Advanced Solid Tumor, B Cell Lymphoma, Hemic and Lymphatic Diseases, +9 more
Locations: Mater Medical Centre Brisbane, Queensland, Austria

View Trial Details

Completed

Anti-CD19 White Blood Cells for Children and Young Adults With B Cell Leukemia or Lymphoma

NCT01593696

Conditions: ALL, B Cell Lymphoma, Dendritic Cell Sarcoma, Interdigitating, +16 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia

NCT01109069

Conditions: B Cell Lymphoma, B-Cell Diffuse Lymphoma, B-cell Chronic Lymphocytic Leukemia, +41 more
Locations: Stanford University Stanford, California, United States

Stanford, California, United States

University of Chicago Chicago, Illinois, United States

Boston, Massachusetts, United States

View all 16 locations

View Trial Details

Completed

Phase I/IIA Study of CART19 Cells for Patients With Chemotherapy Resistant or Refractory CD19+ Leukemia and Lymphoma

NCT01626495

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: CHOP - http://www.chop.edu/service/oncology/pediatric-cancer-research/cart-19-trial.html Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Association of Velcade to R-CHOP in the Treatment of B Cell Lymphoma

NCT00169468

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations: Hôpital Saint-Louis Paris, Paris 10, France

Institut Gustave Roussy Villejuif, Villejuif Cedex, France

Hôpital Henri Mondor Créteil, France

Hôpital Lyon Sud Pierre-Bénite, France

View Trial Details

Completed

CD19-targeting 3rd Generation CAR T Cells for Refractory B Cell Malignancy - a Phase I/IIa Trial.

NCT02132624

Conditions: B Cell Leukemia, B Cell Lymphoma, Hematologic Diseases, +13 more
Locations: Uppsala University Hospital, Dept of Oncology Uppsala, Sweden

View Trial Details

Completed

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

NCT00001512

Conditions: B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +10 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

NCT00001572

Conditions: B Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +11 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

Study of Canfosfamide in Refractory or Relapsed Mantle Cell, Diffuse Large B Cell Lymphoma and Multiple Myeloma

NCT01148108

Conditions: B Cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +19 more
Locations: Cancer Institute of New Jersey New Brunswick, New Jersey, United States

View Trial Details

Completed

A Phase 1 Study of SB1518 for the Treatment of Advanced Lymphoid Malignancies

NCT00741871

Conditions: B Cell Lymphoma, Hemic and Lymphatic Diseases, Hodgkin Disease, +12 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

B Cell Lymphoma

B Cell Lymphoma trial results

Related conditions